SCHEMBL688946

SCHEMBL688946

CCOc1cccc([C@H](CC(=O)O)NC(=O)Nc2c(O)c(C)cn(Cc3c(Cl)cccc3OCC(C)C)c2=O)c1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
FFAR1 O14842 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
PPARG P37231 1/20 0.33
ITGB1 P05556 2/20 0.32
ITGA4 P13612 2/20 0.32
PTGER3 P43115 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
MAPT P10636 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686989 0.95 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1ALDH1A1KDM4EPPARG
SCHEMBL686996 0.93 P2RX3 (0.35) SMN1; SMN2FFAR1ALDH1A1KDM4EPPARG
SCHEMBL687688 0.92 SMN1; SMN2 (0.37) SMN1; SMN2FFAR1ALDH1A1KDM4EPPARG
SCHEMBL688501 0.92 SMN1; SMN2 (0.40) SMN1; SMN2FFAR1ALDH1A1KDM4EPTGER3
SCHEMBL687119 0.92 SMN1; SMN2 (0.36) SMN1; SMN2FFAR1ALDH1A1KDM4EPPARG
SCHEMBL688507 0.91 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1ALDH1A1KDM4EITGB1
SCHEMBL693144 0.91 KDM4E (0.37) SMN1; SMN2FFAR1ALDH1A1KDM4EITGB1
SCHEMBL687802 0.90 CTSA (0.34) SMN1; SMN2FFAR1ALDH1A1KDM4EPPARG
SCHEMBL687907 0.90 SMN1; SMN2 (0.38) SMN1; SMN2FFAR1ALDH1A1KDM4EITGB1
SCHEMBL688273 0.89 CTSA (0.38) ALDH1A1KDM4ENPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed